nabilone sold brand name cesamet among others synthetic cannabinoid therapeutic use antiemetic adjunct analgesic neuropathic mimics tetrahydrocannabinol thc primary psychoactive compound found naturally occurring food drug administration united states indicated nabilone chemotherapyinduced nauseavomiting countries canada widely used adjunct therapy chronic pain management numerous trials case studies demonstrated modest effectiveness relieving multiple nabilone used treat nausea vomiting people nabilone shown modest effectiveness relieving systematic review cannabinoids chronic pain determined evidence safety modest efficacy main settings seen published clinical trials nabilone include movement disorders parkinsonism chronic pain dystonia spasticity neurological disorders multiple sclerosis nausea cancer chemotherapy nabilone also effective treatment inflammatory bowel disease especially ulcerative colitis one study current daily users cannabis oral nabilone mg produced sustained dosedependent mood elevation psychomotor slowing comparable mg oral dronabinol thc nabilone slower onset peak action greater dosedependence effects investigators attributed greater bioavailability study comparing nabilone metoclopramide conducted development modern antagonist antiemetics ondansetron revealed patients taking cisplatin chemotherapy preferred metoclopramide patients taking carboplatin preferred nabilone control nausea nabilone sometimes used nightmares posttraumatic stress disorder studies longer nine weeks effects longerterm use nabilone also used medication overuse nabilone increase rather decrease postoperative pain treatment fibromyalgia adverse effects limit useful adverse effects nabilone include limited dizzinessvertigo euphoria drowsiness dry mouth ataxia sleep disturbance headache nausea disorientation depersonalization hallucinations nabilone partial agonist cannabinoid nabilone given mg doses multiple times day total mg completely absorbed oral administration highly plasma protein bound multiple cytochrome enzymes extensively metabolize nabilone various metabolites fully nabilone racemic mixture consisting ss nabilone originally developed eli lilly company first approved health canada shortly followed approval mexico united kingdom germany lilly received fda approval market withdrew approval commercial valeant pharmaceuticals acquired rights lilly valeant tried failed get medication approved fda succeeded valeant acquired united kingdom european union rights market nabilone cambridge nabilone approved austria treat chemotherapyinduced nausea already approved spain indication legal belgium treat glaucoma spasticity multiple sclerosis wasting due aids chronic httpsenwikipediaorgwikinabilone